SPARCNSESun Pharma Advanced Research Company Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 6 Jan · 17:24 IST

SPARC: Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

SPARC has submitted a routine quarterly compliance certificate under SEBI's Depositories and Participants Regulations. The certificate, issued by the company's Registrar and Share Transfer Agent MUFG Intime (India) Private Limited, confirms that all securities received for dematerialization during the quarter ended December 31, 2025 were processed and confirmed to the depositories. The physical certificates were duly cancelled after verification, and the names of the depositories were substituted as registered owners in the company's member records within the required timelines. MUFG Intime also noted that no rematerialization requests were received during the quarter.

Likely market impact

This is a standard regulatory compliance filing with no material impact on the company's financials, operations, or share price. It simply confirms that the company's share transfer processes are functioning normally.